Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

SN-38 overcomes chemoresistance of colorectal cancer cells induced by hypoxia, through HIF1alpha.

Murono K, Tsuno NH, Kawai K, Sasaki K, Hongo K, Kaneko M, Hiyoshi M, Tada N, Nirei T, Sunami E, Takahashi K, Kitayama J.

Anticancer Res. 2012 Mar;32(3):865-72.

PMID:
22399605
2.

Hypoxia induced paclitaxel resistance in human ovarian cancers via hypoxia-inducible factor 1alpha.

Huang L, Ao Q, Zhang Q, Yang X, Xing H, Li F, Chen G, Zhou J, Wang S, Xu G, Meng L, Lu Y, Ma D.

J Cancer Res Clin Oncol. 2010 Mar;136(3):447-56. doi: 10.1007/s00432-009-0675-4. Epub 2009 Sep 16.

PMID:
19760195
3.

[Impact of RNA interference targeting hypoxia-inducible factor-1alpha on chemosensitivity in esophageal squamous cell carcinoma cells under hypoxia].

Wu XA, Sun Y, Fan QX, Wang LX, Wang RL, Zhang L.

Zhonghua Yi Xue Za Zhi. 2007 Oct 9;87(37):2640-4. Chinese.

PMID:
18162154
4.

[Combination with SN-38 on human colon cancer LoVo cells].

Wang Y, Xu JM, Xu QZ, Zhou PK, Song ST.

Zhonghua Zhong Liu Za Zhi. 2009 Oct;31(10):746-851. Chinese.

PMID:
20021826
5.
6.

An Akt/hypoxia-inducible factor-1alpha/platelet-derived growth factor-BB autocrine loop mediates hypoxia-induced chemoresistance in liver cancer cells and tumorigenic hepatic progenitor cells.

Lau CK, Yang ZF, Ho DW, Ng MN, Yeoh GC, Poon RT, Fan ST.

Clin Cancer Res. 2009 May 15;15(10):3462-71. doi: 10.1158/1078-0432.CCR-08-2127. Epub 2009 May 15.

7.

Characterization of p53 wild-type and null isogenic colorectal cancer cell lines resistant to 5-fluorouracil, oxaliplatin, and irinotecan.

Boyer J, McLean EG, Aroori S, Wilson P, McCulla A, Carey PD, Longley DB, Johnston PG.

Clin Cancer Res. 2004 Mar 15;10(6):2158-67.

8.

[Effect of hypoxia on the chemotherapeutic sensitivity of human ovarian cancer cells to paclitaxel and its mechanism].

Huang L, Zhang QH, Ao QL, Xing H, Lu YP, Ma D.

Zhonghua Zhong Liu Za Zhi. 2007 Feb;29(2):96-100. Chinese.

PMID:
17645840
9.

Hypoxia induced multidrug resistance of laryngeal cancer cells via hypoxia-inducible factor-1α.

Li DW, Dong P, Wang F, Chen XW, Xu CZ, Zhou L.

Asian Pac J Cancer Prev. 2013;14(8):4853-8.

10.

Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancer.

Fioravanti A, Canu B, Alì G, Orlandi P, Allegrini G, Di Desidero T, Emmenegger U, Fontanini G, Danesi R, Del Tacca M, Falcone A, Bocci G.

Eur J Pharmacol. 2009 Oct 1;619(1-3):8-14. doi: 10.1016/j.ejphar.2009.08.020. Epub 2009 Aug 18.

PMID:
19695243
11.

Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer.

Baker AF, Koh MY, Williams RR, James B, Wang H, Tate WR, Gallegos A, Von Hoff DD, Han H, Powis G.

Pancreas. 2008 Mar;36(2):178-86. doi: 10.1097/MPA.0b013e31815929fe.

PMID:
18376310
12.

Contribution of HIF-1 and drug penetrance to oxaliplatin resistance in hypoxic colorectal cancer cells.

Roberts DL, Williams KJ, Cowen RL, Barathova M, Eustace AJ, Brittain-Dissont S, Tilby MJ, Pearson DG, Ottley CJ, Stratford IJ, Dive C.

Br J Cancer. 2009 Oct 20;101(8):1290-7. doi: 10.1038/sj.bjc.6605311. Epub 2009 Sep 15.

13.

Inducible nuclear factor-kappaB activation contributes to chemotherapy resistance in gastric cancer.

Camp ER, Li J, Minnich DJ, Brank A, Moldawer LL, MacKay SL, Hochwald SN.

J Am Coll Surg. 2004 Aug;199(2):249-58.

PMID:
15275881
14.

Synergistic antitumor effects of endostar in combination with oxaliplatin via inhibition of HIF and CXCR4 in the colorectal cell line SW1116.

Jin F, Ji H, Jia C, Brockmeier U, Hermann DM, Metzen E, Zhu Y, Chi B.

PLoS One. 2012;7(10):e47161. doi: 10.1371/journal.pone.0047161. Epub 2012 Oct 10.

15.

Marked activity of irinotecan and rapamycin combination toward colon cancer cells in vivo and in vitro is mediated through cooperative modulation of the mammalian target of rapamycin/hypoxia-inducible factor-1alpha axis.

Pencreach E, Guérin E, Nicolet C, Lelong-Rebel I, Voegeli AC, Oudet P, Larsen AK, Gaub MP, Guenot D.

Clin Cancer Res. 2009 Feb 15;15(4):1297-307. doi: 10.1158/1078-0432.CCR-08-0889. Epub 2009 Feb 3.

17.

Expression levels and significance of hypoxia inducible factor-1 alpha and vascular endothelial growth factor in human colorectal adenocarcinoma.

Jiang CQ, Fan LF, Liu ZS, Qian Q, Xia D, Diao LM, He YM, Ai ZL.

Chin Med J (Engl). 2004 Oct;117(10):1541-6.

PMID:
15498380
18.

Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.

Song X, Liu X, Chi W, Liu Y, Wei L, Wang X, Yu J.

Cancer Chemother Pharmacol. 2006 Dec;58(6):776-84. Epub 2006 Mar 11.

PMID:
16532342
19.
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk